BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 21450488)

  • 1. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual disease at the bronchial stump after curative resection for lung cancer.
    Wind J; Smit EJ; Senan S; Eerenberg JP
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):29-34. PubMed ID: 17466532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sleeve resections in advanced nodal disease.
    Schirren J; Eberlein M; Fischer A; Bölükbas S
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1157-63. PubMed ID: 21454086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis.
    Hung JJ; Jeng WJ; Hsu WH; Wu KJ; Chou TY; Hsieh CC; Huang MH; Liu JS; Wu YC
    Thorax; 2010 Mar; 65(3):241-5. PubMed ID: 20335294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy.
    Sienel W; Stremmel C; Kirschbaum A; Hinterberger L; Stoelben E; Hasse J; Passlick B
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):522-7; discussion 527-8. PubMed ID: 17229574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis of non-small cell lung cancer patients with microscopic residual disease at bronchial stump after lung resection].
    Dai W; Yu C; Sun Y
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1022-4. PubMed ID: 12194790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
    Schuchert MJ; Pettiford BL; Keeley S; D'Amato TA; Kilic A; Close J; Pennathur A; Santos R; Fernando HC; Landreneau JR; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2007 Sep; 84(3):926-32; discussion 932-3. PubMed ID: 17720401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial resection margin and long-term survival in non-small-cell lung cancer.
    Poullis M; McShane J; Shaw M; Page R; Woolley S; Shackcloth M; Mediratta N
    Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):432-8. PubMed ID: 22879550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine intraoperative frozen section analysis of bronchial margins is of limited utility in lung cancer resection.
    Owen RM; Force SD; Gal AA; Feingold PL; Pickens A; Miller DL; Fernandez FG
    Ann Thorac Surg; 2013 Jun; 95(6):1859-65; discussion 1865-6. PubMed ID: 23415238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
    Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.